Health Care Hcs245 Article Review

Journal Article Review: Faecal Microbiota Transplant
HCS245


                    Journal Article Review: Faecal Microbiota Transplant
      The article that this writer is reviewing is about therapeutic faecal microbiota transplant (FMT).   FMT is the transplanting of fecal bacteria from a healthy donor to a recipient, and is known as a stool transplant.   This writer watched a report on this subject on a television show sometime last year.   Since the writer thought it was an interesting subject, the writer did some research and found a pertinent article in the Current Opinion in Gastroenterology journal on line.   The primary Australian researcher, Dr. Thomas Borody, is the founder and medical director of the Australian Center for Digestive Diseases.   Believing that bacteria in the intestines and toxins that enter the body through the intestines have many ill effects on the body, Dr. Borody advocates FMT as a cure for many diseases, ranging from C. difficile infection (CDI), to ulcerative colitis to Crohn’s to possibly Parkinson’s (Borody, Brandt, & Paramsothy, 2014) .  
                                                    Claims
      The main claim of the article is that the human gut is the gateway for pathogens and toxins to enter the body. It claims that these pathogens and toxins cause not only gastrointestinal diseases such as colitis and Crohn’s, but also diseases that are seemingly unrelated to gastroenterology such as rheumatoid arthritis, Parkinson’s, and autism.   The article makes the claim that FMT treatment can ease the symptoms or entirely cure these diseases.   During the last year, there has been a growing interest worldwide, as more knowledge and understanding has been gained about gastrointestinal microbiota (GiMb) and the affects that the bacteria in the gut can have on the rest of the body.   Groups such as the Human Microbiome Project and the Metagenomics of the Human Intestinal Tract (MetaHIT) were established to research the...